secwatch.observer — SEC 8-K summary
======================================

Issuer:     Context Therapeutics Inc. (CNTX)
CIK:        0001842952
Form:       8-K
Filed at:   2026-07-31T20:08:44+00:00
Accession:  0001628280-26-051399
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Context Therapeutics receives Nasdaq deficiency notice for bid price below $1.00
--------------------------------------------------------------------------------

- Nasdaq notified Context on July 29, 2026 of non-compliance with Minimum Bid Price Rule (bid below $1.00 for 30 consecutive business days).
- Company has 180 calendar days, until January 25, 2027, to regain compliance by closing at $1.00 or more for 10 consecutive business days.
- If not compliant by Jan 25, 2027, may be eligible for a second 180-day period if it meets other listing standards and notifies Nasdaq of intent to cure.
- Company intends to monitor bid price and evaluate options, but no assurance of regaining compliance or avoiding delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842952/000162828026051399/0001628280-26-051399-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842952/000162828026051399/cntx-20260729.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-051399

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer